Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study

MicroRNAs (miRs) have emerged as biomarkers of migraine disease in both adults and children. In this study we evaluated the expression of hsa-miR-34a-5p and hsa-miR-375 in serum and saliva of young subjects (age 11 ± 3.467 years) with migraine without aura (MWA), while some underwent pharma...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Luca Gallelli, Erika Cione, Fancesco Peltrone, Serena Siviglia, Antonio Verano, Domenico Chirchiglia, Stefania Zampogna, Vincenzo Guidetti, Luca Sammartino, Angelo Montana, Maria Cristina Caroleo, Giovambattista De Sarro, Giulio Di Mizio
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2019-06-01
Collection:Journal of Clinical Medicine
Sujets:
biomarkers
miRs
saliva
blood
pain-migraine
drug treatment
clinical risk management
Accès en ligne:https://www.mdpi.com/2077-0383/8/7/928
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires